Horizon Therapeutics Public Limited Company Ordinary Shares

HZNP

Valor de mercado US$ 26,6 bi

Sobre: Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.

Funcionários: 2.190